🇺🇸 FDA

Intelligence · Drug directory

Drugs Starting With C Intelligence

Browse 434 pharmaceutical drugs starting with "C" — INN profiles with FDA/EMA status, pipeline links, and patents.

Quick answer

NovaPharmaNews lists 434 pharmaceutical drugs whose INN (International Nonproprietary Name) begins with "C". Each profile includes regulatory status, brand names, originator companies, and cross-links to clinical pipeline and patent records.

434 drugs · Letter C · by data quality · Page 16 of 19

  1. coronavirus (sars-cov-2) rna vaccine (active ingredient: ufrenmeran)

    DAICHIRONA (MONOVALENT, ORIGINAL) INITIAL APPROVAL

    PMDA: approved

  2. coronavirus (sars-cov-2) rna vaccine (active ingredients of bivalent original/omicron ba.1 vaccine: elasomeran and imelasomeran) (active ingredients of bivalent original/omicron ba.4-5 vaccine: elasomeran and davesomeran) (active ingredient of monovalent

    SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) (BIVALENT, ORIGINAL/OMICRON BA.4-5) (MONOVALENT, OMICRON XBB.1.5) PARTIAL CHANGE APPROVAL

    PMDA: approved

  3. coronavirus (sars-cov-2) rna vaccine (active ingredients: elasomeran and davesomeran)

    SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL

    PMDA: approved

  4. coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)

    COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL

    PMDA: approved

  5. coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: elasomeran)

    SPIKEVAX (PREVIOUSLY COVID-19 VACCINE MODERNA) (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL

    PMDA: approved

  6. coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredient: tozinameran)

    COMIRNATY (NOTE 2) (MONOVALENT, ORIGINAL) INITIAL APPROVAL

    PMDA: approved

  7. coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: elasomeran and imelasomeran)

    SPIKEVAX (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL

    PMDA: approved

  8. coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and famtozinameran)

    COMIRNATY FOR 5 TO 11 YEARS OLD (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL

    PMDA: approved

  9. coronavirus modified uridine rna vaccine (sars-cov-2) (active ingredients: tozinameran and riltozinameran)

    COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.1) PARTIAL CHANGE APPROVAL

    PMDA: approved

  10. covid-19 (sars-cov-2) vaccine (recombinant adenovirus vector)

    JCOVDEN

    PMDA: approved

  11. covid-19 (sars-cov-2) vaccine (recombinant chimpanzee adenovirus vector)

    VAXZEVRIA (NOTE 2)

    PMDA: approved

  12. creams

    NULL

    TGA: approved

  13. cacag

    NMPA: clinical trials

  14. cadonilimab

    NMPA: clinical trials

  15. calcitonin

    NMPA: clinical trials

  16. camrelizumab

    NMPA: clinical trials

  17. canakinumab-matching

    NMPA: clinical trials

  18. capeox

    NMPA: clinical trials

  19. capsule

    NMPA: clinical trials

  20. capsules

    NMPA: clinical trials

  21. car-t

    NMPA: clinical trials

  22. car-transduced

    NMPA: clinical trials

  23. carleilizumab

    NMPA: clinical trials

  24. carrellizumab

    NMPA: clinical trials

Frequently asked questions

How many drugs start with C?

434 published drug profiles in our index begin with "C".

How do I find a drug by brand name?

Use the search box on the main drugs directory — it matches INN, slug, and therapeutic class. Brand names appear on each drug profile row.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.